1890208-58-8

Basic information

• Product Name: Compound 7P
• Synonyms: Compound 7P
• CAS NO: 1890208-58-8
• Molecular Formula: C22H23N3O5S
• Molecular Weight: 441.5
• Mol File: 1890208-58-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.329±0.06 g/cm3(Predicted)
• PKA: 11?+-.0.70(Predicted)
• CAS DataBase Reference: Compound 7P(CAS DataBase Reference)
• NIST Chemistry Reference: Compound 7P(1890208-58-8)
• EPA Substance Registry System: Compound 7P(1890208-58-8)

Safety Data

• Hazardous Substances Data: 1890208-58-8(Hazardous Substances Data)

Usage

General Description

Compound 7P is a chemical compound that is primarily used as a pharmaceutical ingredient in the production of medications such as anticancer agents. It is a potent inhibitor of the enzyme topoisomerase I, which is responsible for unwinding and winding the DNA helix during DNA replication. This inhibition disrupts the replication and transcription process, leading to the arrest of cells in the S-phase of the cell cycle and ultimately resulting in apoptosis, or programmed cell death. Compound 7P has shown promising results in preclinical studies, demonstrating its potential as a valuable tool in the development of new cancer treatments. Its unique mechanism of action and high potency make it a significant chemical in the field of medicinal chemistry and drug discovery.

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 33631-09-3 4-methoxypyridin-3-amine 
• 6295-94-9 N-tosyl-2-anisidine 
• 90-04-0 2-methoxy-phenylamine 

Relevant articles and documents

Discovery, Optimization, and Biological Evaluation of Sulfonamidoacetamides as an Inducer of Axon Regeneration

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential, and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways. Here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. In an animal model of optic nerve injury, compound 7p was shown to induce growth of GAP-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo. Further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.